Guidelines for the prevention of intravascular catheter–related infections NP O'grady, M Alexander, EP Dellinger, JL Gerberding, SO Heard, ... Clinical infectious diseases 35 (11), 1281-1307, 2002 | 7944* | 2002 |
Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock RP Dellinger, JM Carlet, H Masur, H Gerlach, T Calandra, J Cohen, ... Critical care medicine 32 (3), 858-873, 2004 | 6324 | 2004 |
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 L Evans, A Rhodes, W Alhazzani, M Antonelli, CM Coopersmith, C French, ... Critical care medicine 49 (11), e1063-e1143, 2021 | 3638 | 2021 |
An Outbreak of Community-Acquired Pneumocystis carinii Pneumonia: Initial Manifestation of Cellular Immune Dysfunction H Masur, MA Michelis, JB Greene, I Onorato, RA Vande Stouwe, ... New England journal of medicine 305 (24), 1431-1438, 1981 | 2291 | 1981 |
Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome HC Lane, H Masur, LC Edgar, G Whalen, AH Rook, AS Fauci New England Journal of Medicine 309 (8), 453-458, 1983 | 2080 | 1983 |
Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents JE Kaplan, C Benson, KK Holmes, JT Brooks, A Pau, H Masur, ... MMWR Recomm Rep 58 (4), 1-207, 2009 | 2038 | 2009 |
Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group … JP Donnelly, SC Chen, CA Kauffman, WJ Steinbach, JW Baddley, ... Clinical Infectious Diseases 71 (6), 1367-1376, 2020 | 1868 | 2020 |
Acquired immunodeficiency syndrome: epidemiologic, clinical, immunologic, and therapeutic considerations AS Fauci, AM Macher, DL Longo, HC Lane, AH ROOK, H MASUR, ... Annals of internal medicine 100 (1), 92-106, 1984 | 1133 | 1984 |
Pneumocystis carinii Pneumonia: A Comparison Between Patients with the Acquired Immunodeficiency Syndrome and Patients with Other Immunodeficiencies JA Kovacs, JW Hiemenz, AM Macher, D STOVER, HW MURRAY, ... Annals of internal medicine 100 (5), 663-671, 1984 | 1067 | 1984 |
HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression RT Davey Jr, N Bhat, C Yoder, TW Chun, JA Metcalf, R Dewar, ... Proceedings of the National Academy of Sciences 96 (26), 15109-15114, 1999 | 1053 | 1999 |
Ribosomal RNA sequence shows Pneumocystis carinii to be a member of the Fungi JC Edman, JA Kovacs, H Masur, DV Santi, HJ Elwood, ML Sogin Nature 334 (6182), 519-522, 1988 | 1025 | 1988 |
1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus H Masur, JE Kaplan, KK Holmes, BL Alston, N Ampel, JR Anderson, ... Clinical Infectious Diseases 30, S29-S65, 2000 | 963* | 2000 |
Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup Surviving sepsis campaign: international guidelines for management of severe sepsis and septic … RP Dellinger, MM Levy, A Rhodes, D Annane, H Gerlach, SM Opal, ... Crit Care Med 41 (2), 580-637, 2013 | 929 | 2013 |
Guidelines for preventing opportunistic infections among HIV-infected persons—2002: recommendations of the US Public Health Service and the Infectious Diseases Society of America PH Masur, JE Kaplan, KK Holmes Annals of internal medicine 137 (5_Part_2), 435-478, 2002 | 847 | 2002 |
Hepatitis C guidance: AASLD‐IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus AASLD/IDSA HCV Guidance Panel, RT Chung, GL Davis, DM Jensen, ... Hepatology 62 (3), 932-954, 2015 | 830 | 2015 |
Cryptococcosis in the acquired immunodeficiency syndrome JA KOVACS, AA Kovacs, M Polis, WC Wright, VJ Gill, CU Tuazon, ... Annals of internal medicine 103 (4), 533-538, 1985 | 777 | 1985 |
Guidelines for evaluation of new fever in critically ill adult patients: 2008 update from the American College of Critical Care Medicine and the Infectious Diseases Society of … NP O’Grady, PS Barie, JG Bartlett, T Bleck, K Carroll, AC Kalil, P Linden, ... Critical care medicine 36 (4), 1330-1349, 2008 | 744 | 2008 |
CD4 counts as predictors of opportunistic pneumonias in human immunodeficiency virus (HIV) infection H Masur, FP Ognibene, R Yarchoan, JH Shelhamer, BF Baird, W Travis, ... Annals of internal medicine 111 (3), 223-231, 1989 | 719 | 1989 |
Impaired production of lymphokines and immune (gamma) interferon in the acquired immunodeficiency syndrome HW Murray, BY Rubin, H Masur, RB Roberts New England Journal of Medicine 310 (14), 883-889, 1984 | 675 | 1984 |
HIV infection induces changes in CD4+ T-cell phenotype and depletions within the CD4+ T-cell repertoire that are not immediately restored by antiviral or immune … M Connors, JA Kovacs, S Krevat, JC Gea-Banacloche, MC Sneller, ... Nature medicine 3 (5), 533-540, 1997 | 638 | 1997 |